James F Cleary

基本信息

浏览量：74

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 426 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Nivolumab (NIVO) + Chemotherapy (chemo) Vs Chemo As First-Line (1L) Treatment for Advanced Gastric Cancer/gastroesophageal Junction Cancer/esophageal Adenocarcinoma (GC/GEJC/EAC): 5-Year (y) Follow-Up Results from CheckMate 649

Yelena Y. Janjigian,Markus H. Moehler,Jaffer A. Ajani,Lin Shen,Marcelo Garrido,Carlos Gallardo,Lucjan Wyrwicz,Kensei Yamaguchi,James M. Cleary,Elena Elimova, Ricardo Elias Bruges,Michalis Karamouzis,Tomasz Skoczylas,Arinilda Bragagnoli,Tianshu Liu,Mustapha Tehfe, Stephen McCraith,Nan Hu, Jennifer Zhang,Kohei Shitara

Journal of Clinical Oncologyno. 4_suppl (2025): 398-398

引用0浏览0引用

The Prognostic Value of HER2 Gene Dosage and Heterogeneity at a Single-Cell Resolution in Gastroesophageal Adenocarcinoma

Yashika Parashar, Leigh Culnane,Joshua Remland,Chetan Nambiar, Chen Yuan, Shagun Nasta,Adam Bard,Haeseong Park,Samuel J. Klempner,Marios Giannakis,Andrew Aguirre,Kimmie Ng,Jeffrey A. Meyerhardt, Brian M. Wolpin,Rona Yaeger,James M. Cleary, Charlotte Wang,Peter C. Enzinger,Nilay S. Sethi,Harshabad Singh

Journal of Clinical Oncologyno. 4_suppl (2025): 473-473

引用0浏览0引用

Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer

The New England journal of medicineno. 6 (2025): 566-576

引用0浏览0WOS引用

Supplementary Figure S3 from A Translational Study of the ATR Inhibitor Berzosertib As Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

Gregory M. Cote,Bose S. Kochupurakkal,Khanh Do,Andrea Bullock,Michael L. Cheng,Alona Muzikansky,Daniel E. McLoughlin,James M. Cleary, Xin Gao,Aparna Parikh,Jong Chul Park,Colin D. Weekes,Oladapo Yeku,Lee Zou,Geoffrey I. Shapiro

crossref（2025）

引用0浏览0引用

Supplementary Figure S1 from A Translational Study of the ATR Inhibitor Berzosertib As Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

crossref（2025）

引用0浏览0引用

A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer

CANCER IMMUNOLOGY RESEARCHno. 1 (2025): 9-22

引用0浏览0WOS引用

Supplementary Figure S4 from A Translational Study of the ATR Inhibitor Berzosertib As Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

crossref（2025）

引用0浏览0引用

A Translational Study of the ATR Inhibitor Berzosertib As Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

Gregory M. Cote,Bose S. Kochupurakkal,Khanh Do,Andrea Bullock,Michael L. Cheng,Alona Muzikansky,Daniel E. Mcloughlin,James M. Cleary, Xin Gao,Aparna Parikh,Jong Chul Park,Colin D. Weekes,Oladapo Yeku,Lee Zou,Geoffrey I. Shapiro

CLINICAL CANCER RESEARCHno. 1 (2025): 35-44

引用0浏览0WOS引用

CITRINO: Phase 1 Dose Escalation Study of Anti-Lag-3 Antibody Encelimab Alone or in Combination with Anti-Pd-1 Dostarlimab in Patients with Advanced/metastatic Solid Tumours

J Randolph Hecht,Jean-Marie Michot, David Bajor,Amita Patnaik, Ki Y Chung,Judy Wang,Gerald Falchook,James M Cleary, Richard Kim, Anuradha Krishnamurthy, Omkar Marathe,Hagop Youssoufian,Catherine Ellis, Angela Waszak,Srimoyee Ghosh, Hailei Zhang, Kaitlin Yablonski, Shruti D Shah, Ivan Diaz-Padilla,Susanna Ulahannan

BJC reportsno. 1 (2025): 10-10

引用0浏览0WOSNATURE引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

教授

论文共 426 篇作者统计合作学者相似作者